Klaus Pantel

Klaus Pantel is a Professor at the Institute of Tumor Biology within the University Medical Center Hamburg-Eppendorf, a leading institution in biomedical research. His work focuses on liquid biopsy technologies, particularly the detection and characterization of circulating tumor cells (CTCs) and cell-free DNA for cancer diagnosis, treatment monitoring, and resistance mechanisms.

• Key research projects include European Liquid Biopsy Society (ELBS) initiatives, RAI2 protein function in castration-resistant prostate cancer, and brain metastasis prevention strategies.
• His recent publications highlight advances in machine learning-based CTC detection, immune checkpoint inhibition biomarkers, and metastasis biology.
• He contributes to clinical translation through PREDICT Global Pooled Analysis and collaborations with EFPIA partners for postdoctoral funding.